Search
SOLACI Congress
SOLACI CongressesSOLACI-SBHCI 2023

SOLACI-SBHCI 23

solaci
solaci
35
0

Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress.

If you cannot view the articles, click here.

Previous article
Download the Official Congress APP Right Now
Next article
SOLACI-SBHCI 2023 Congress Has Begun!
solaci
solaci

More articles by this author

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci - 0
✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words - Dra. Emma Miranda (MEX)...

SOLACI-SOCIME 22

solaci - 0
Here you will find the most relevant articles about the SOLACI-SOCIME 2022 Congress. If you cannot view the articles, click here.

SOLACI-CACI 21

solaci - 0
Here you will find the most relevant articles about the SOLACI-CACI 2021 Congress. If you cannot view the articles, click here.

SOLACI-SBHCI 2019

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2019 Congress, held on August 1st, 2nd & 3rd at Frei Caneca Convention...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

CONGRESS

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words -...
solaci -
SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy